1,4,7-triazacyclononane-n,n',n''-triacetic acid and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 18 studies

Compound Research Comparison

Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid)	Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid)	Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid)	Studies (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)	Trials (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)	Recent Studies (post-2010) (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
195	3	161	792	16	476

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (5.56)	18.2507
2000's	0 (0.00)	29.6817
2010's	16 (88.89)	24.3611
2020's	1 (5.56)	2.80

Authors

Authors	Studies
Boden, J; Boden, R; Boyce, B; Farnsworth, AP; King, DJ; Millar, K; Millican, TA; Pedley, RB; Rhind, SK; Turner, A	1
Chung, JK; Jeong, JM; Ju, CH; Kim, YJ; Lee, DS; Lee, JY; Lee, MC; Lee, YS; Shetty, D	1
Dearling, JL; Dunning, P; Fahey, F; Huston, JS; Meares, CF; Packard, AB; Smith, SV; Snay, E; Treves, ST; Voss, SD	1
Baumhover, NJ; Kloepping, KC; Martin, ME; O'Dorisio, MS; Parameswarappa, SG; Pigge, FC; Schultz, MK	1
Hann, S; Koellensperger, G; Kretschy, D	1
Barnhart, TE; Bean, J; Cai, W; Engle, JW; Hong, H; Leigh, BR; Yang, Y; Zhang, Y	1
Altai, M; Braun, A; Garske, U; Karlström, AE; Malmberg, J; Orlova, A; Perols, A; Sandström, M; Tolmachev, V; Varasteh, Z	1
Desai, AV; Kenis, PJ; Ranganathan, D; Reichert, DE; Wheeler, TD; Zeng, D	1
Bérubé-Lauzière, Y; Guérin, B; Klarskov, K; Lebel, R; Lecomte, R; Ranyuk, E; van Lier, JE	1
Orvig, C; Price, EW	1
Asti, M; Atti, G; Bergmann, R; Brennauer, A; Capponi, PC; Erba, PA; Iori, M; Martin, R; Müller, M; Rubagotti, S; Versari, A	1
Blower, PJ; Boerman, OC; Burnet, J; Cooper, MS; Foster, JM; Hudson, C; Joosten, L; Kolenc-Peitl, PK; Laverman, P; Leyton, J; Mather, SJ; Oyen, WJ; Roosenburg, S; Sosabowski, JK	1
Arvidsson, PI; Bester, LA; Chonco, L; Essack, SY; Govender, T; Kruger, HG; Naicker, T; Parboosing, R; Somboro, AM; Tiwari, D	1
Chen, J; Chen, Z; Lisok, A; Mease, RC; Pomper, MG; Pullambhatla, M; Ray Banerjee, S	1
Chen, H; Chen, X; Jacobson, O; Kiesewetter, DO; Liu, Y; Ma, Y; Niu, G; Weiss, ID; Wu, H	1
Amirdhanayagam, J; Das, T; Dash, A; Guleria, M; Sarma, HD	1
Bailly, C; Bourgeois, M; Bris, NL; Chérel, M; Faivre-Chauvet, A; Le Bihan, T; Le Saëc, P; Navarro, AS; Saï-Maurel, C; Tripier, R	1
Appelhans, D; Boye, S; Daeg, J; Janke, A; Lederer, A; Shi, X; Temme, A; Voit, B; Xu, X; Zhao, J; Zhao, L	1

Reviews

1 review(s) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

Article	Year
Matching chelators to radiometals for radiopharmaceuticals. Chemical Society reviews, 2014, Jan-07, Volume: 43, Issue:1 Topics: Chelating Agents; Chlorobenzenes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcosine; Thermodynamics; Tomography, Emission-Computed, Single-Photon	2014

Other Studies

17 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

Article	Year
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice. British journal of cancer, 1994, Volume: 70, Issue:1 Topics: Amines; Animals; Antibodies, Monoclonal; Chelating Agents; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Ligands; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Pentetic Acid; Radionuclide Imaging; Recombinant Fusion Proteins; Tissue Distribution; Tumor Cells, Cultured	1994
Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography. Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21 Topics: Animals; Blood Proteins; Cell Line, Tumor; Chelating Agents; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Neoplasms; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals	2010
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. Nuclear medicine and biology, 2011, Volume: 38, Issue:1 Topics: Aniline Compounds; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Copper Radioisotopes; Cross-Linking Reagents; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Melanoma; Mice; Positron-Emission Tomography	2011
Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry. Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19 Topics: alpha-MSH; Animals; Azides; Cell Line, Tumor; Chelating Agents; Click Chemistry; Copper; Copper Radioisotopes; Drug Evaluation, Preclinical; Drug Stability; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Protein Binding; Radiopharmaceuticals; Sensitivity and Specificity	2011
Stability assessment of different chelating moieties used for elemental labeling of bio-molecules. Metallomics : integrated biometal science, 2011, Volume: 3, Issue:12 Topics: Chelating Agents; Chromatography; Coordination Complexes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Pentetic Acid; Temperature	2011
Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA. PloS one, 2011, Volume: 6, Issue:12 Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Cell Line, Tumor; Copper Radioisotopes; Endoglin; Flow Cytometry; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Human Umbilical Vein Endothelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Mice; Positron-Emission Tomography; Receptors, Cell Surface; Staining and Labeling; Tissue Distribution	2011
Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:3 Topics: Acetates; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Binding Sites; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Male; Mice; Molecular Imaging; Molecular Sequence Data; Prostatic Neoplasms; Receptor, ErbB-2; Substrate Specificity	2012
Microfluidic radiolabeling of biomolecules with PET radiometals. Nuclear medicine and biology, 2013, Volume: 40, Issue:1 Topics: Copper Radioisotopes; Dimethylpolysiloxanes; Gallium Radioisotopes; Glass; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Isotope Labeling; Microfluidic Analytical Techniques; Oligopeptides; Positron-Emission Tomography; Temperature; Time Factors	2013
(68)Ga/DOTA- and (64)Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes. Bioconjugate chemistry, 2013, Sep-18, Volume: 24, Issue:9 Topics: Animals; Copper Radioisotopes; Fluorescent Dyes; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Indoles; Isoindoles; Mice; Mice, Nude; Neoplasms; Optical Imaging; Positron-Emission Tomography	2013
Influence of different chelators on the radiochemical properties of a 68-Gallium labelled bombesin analogue. Nuclear medicine and biology, 2014, Volume: 41, Issue:1 Topics: Acetates; Amino Acid Sequence; Bombesin; Chelating Agents; Drug Stability; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Radiochemistry	2014
PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In. Molecular pharmaceutics, 2014, Nov-03, Volume: 11, Issue:11 Topics: Acetates; Animals; Cell Line, Tumor; Chelating Agents; Copper Radioisotopes; Female; Gallium Radioisotopes; Gastrins; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Inhibitory Concentration 50; Mice; Mice, SCID; Multimodal Imaging; Neoplasm Transplantation; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Cholecystokinin B; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2014
NOTA: a potent metallo-β-lactamase inhibitor. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Escherichia coli; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure	2015
Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA. Bioconjugate chemistry, 2016, Jun-15, Volume: 27, Issue:6 Topics: Antigens, Surface; Biological Transport; Cell Line, Tumor; Chelating Agents; Edetic Acid; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiochemistry; Radiopharmaceuticals; Tissue Distribution	2016
Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:4 Topics: Animals; Cell Line, Tumor; Copper Radioisotopes; Evans Blue; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice; Oligopeptides; Positron-Emission Tomography; Radiochemistry; Radiopharmaceuticals; Tissue Distribution; Yttrium Radioisotopes	2017
Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of Cancer biotherapy & radiopharmaceuticals, 2018, Volume: 33, Issue:1 Topics: Animals; Cell Line, Tumor; Chelating Agents; Disease Models, Animal; Fibrosarcoma; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Porphyrins; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution	2018
TE1PA as Innovating Chelator for Bioconjugate chemistry, 2019, 09-18, Volume: 30, Issue:9 Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Chelating Agents; Copper Radioisotopes; Heterocyclic Compounds, 1-Ring; Immunoconjugates; Mice; Multiple Myeloma; Positron-Emission Tomography; Tissue Distribution	2019
Bivalent Peptide- and Chelator-Containing Bioconjugates as Toolbox Components for Personalized Nanomedicine. Biomacromolecules, 2020, 01-13, Volume: 21, Issue:1 Topics: Animals; Antigens, Surface; Avidin; Biotin; Chelating Agents; Contrast Media; Dendrimers; Diagnostic Imaging; ErbB Receptors; Folic Acid; Glutamate Carboxypeptidase II; HEK293 Cells; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanomedicine; Peptides; Polyethylene Glycols; Prostatic Neoplasms; Xenograft Model Antitumor Assays	2020